Mitchell Aaron P
Department of Microbiology, Columbia University, New York, New York 10032, USA.
J Clin Invest. 2006 Jun;116(6):1481-3. doi: 10.1172/JCI28842.
In this issue of the JCI, the observation of the altered pathogenicity of a Cryptococcus neoformans glucosylceramide (GlcCer) mutant shines new light on the initiation of cryptococcal infection. Rittershaus and colleagues demonstrate that the cell surface glycosphingolipid GlcCer is essential for the fungus to grow in the extracellular environments of the host bloodstream and alveolar spaces of the lung, which, in contrast to the acidic intracellular environment of macrophages, are characterized by a neutral pH (see the related article beginning on page 1651). Their findings establish an unexpected connection between this glycosphingolipid and the fungal responses to physiological CO2 and pH. They also focus new attention on the therapeutic potential of anti-GlcCer antibodies found in convalescent sera.
在本期《临床研究杂志》(JCI)中,对新型隐球菌葡糖神经酰胺(GlcCer)突变体致病性改变的观察为隐球菌感染的起始提供了新的线索。里特绍斯及其同事证明,细胞表面糖鞘脂GlcCer对于该真菌在宿主血液的细胞外环境和肺部肺泡空间中生长至关重要,与巨噬细胞的酸性细胞内环境不同,这些环境的特征是中性pH值(见第1651页开始的相关文章)。他们的发现建立了这种糖鞘脂与真菌对生理二氧化碳和pH值反应之间意想不到的联系。他们还将新的注意力集中在康复血清中发现的抗GlcCer抗体的治疗潜力上。